GSK has dropped both GSK3915393, an investigational celiac disease therapeutic, and GSK3878858, a Staphylococcus aureus vaccine hopeful, from its clinical development roster, the company revealed Wednesday.
https://www.pharmalive.com/wp-content/uploads/2023/02/BioSpaceGSK2-1-2023.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2023-02-01 12:15:042023-02-01 12:15:04GSK culls celiac, S. aureus candidates on FDA decision day for CKD drug
